Navigation Links
Genes Linked to Restless Legs Syndrome Identified

THURSDAY, July 14 (HealthDay News) -- An international team of researchers has identified two genetic regions that seem to be implicated in restless legs syndrome.

Restless legs syndrome is a condition in which people experience a tingling or "creepy crawly" feeling in the legs, relieved only by movement. One of the most common neurological diseases, the syndrome can lead to chronic sleep loss, daytime fatigue and even depression.

In the new study, scientists from Europe, Canada and the United States analyzed genetic sequence variants in nearly 5,000 people suffering from restless legs syndrome along with more than 7,000 people who did not have the condition.

The researchers found two new genetic regions that play a role in the syndrome. One of the regions is within a gene involved in regulating brain activity, known as TOX3, according to the report published online July 14 in PLoS Genetics.

Although the exact connection between TOX3 and restless legs syndrome remains unclear, it's known that the TOX3 protein protects neuronal cells from death, Juliane Winkelmann, of the Institute of Human Genetics at the University of Technology in Munich, and colleagues noted in a news release from the journal's publisher.

Restless legs syndrome can strike at any age, although it is more common among people aged 65 and older, the study authors noted in the news release.

More information

The U.S. National Institute of Neurological Disorders and Stroke provides more information on restless legs syndrome.

-- Mary Elizabeth Dallas

SOURCE: Public Library of Science, news release, July 14, 2011

Copyright©2010 ScoutNews,LLC.
All rights reserved

Page: 1

Related medicine news :

1. Those aching joints could be in your genes
2. Mass. General team identifies new class of antiangiogenesis drugs
3. Telomeres: 2 genes linked to why they stretch in cancer cells
4. Fox Chase researchers identify new mechanism used by cells to reverse silenced genes
5. Genes May Control How Long You Look at Happy Faces
6. Advances in delivery of therapeutic genes to treat brain tumors
7. Possible susceptibility genes found in neurodegenerative disorder
8. Penn study identifies genes that may help predict response to BRAF inhibitors for advanced melanoma
9. Scientists identify overactive genes in aggressive breast cancers
10. Genes Tied to Severity of Cystic Fibrosis Identified
11. Outstanding quality of science at 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2011) underlines conference goal of translating HIV research into practice
Post Your Comments:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is ... a fitness app. The fitness app plans to fix the two major problems leading the ... one size fits all type program , They don’t eliminate all the reasons ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... First Choice ... States, named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm ... Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... , June 23, 2016 Research ... Devices Global Market - Forecast to 2022" report to ... the treatment method for the patients with kidney failure, it ... excess fluid from the patient,s blood and thus the treatment ... potassium and chloride in balance. Increasing number ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: